Jim Simons Arca Biopharma, Inc. Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Arca Biopharma, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 65,699 shares of ABIO stock, worth $218,777. This represents 0.0% of its overall portfolio holdings.

Number of Shares

65,699

Previous 57,299 14.66%

Holding current value

$218,777

Previous $97,000 19.59%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.58 - $1.78 $13,272 - $14,952	8,400 Added 14.66%	65,699 $116,000
Q4 2023 Feb 13, 2024	BUY	$1.7 - $2.05 $11,048 - $13,322	6,499 Added 12.79%	57,299 $97,000
Q3 2023 Nov 14, 2023	BUY	$2.01 - $2.07 $12,662 - $13,040	6,300 Added 14.16%	50,800 $102,000
Q2 2023 Aug 11, 2023	BUY	$1.94 - $2.11 $9,312 - $10,128	4,800 Added 12.09%	44,500 $90,000
Q1 2023 May 12, 2023	BUY	$1.99 - $2.55 $8,955 - $11,475	4,500 Added 12.78%	39,700 $79,000

Q4 2022 Feb 13, 2023	BUY	$1.86 - $2.44 $3,162 - $4,148	1,700 Added 5.07%	35,200 $83,000
Q3 2022 Nov 14, 2022	BUY	$2.13 - $2.51 $2,130 - $2,510	1,000 Added 3.08%	33,500 $69,000
Q2 2022 Aug 12, 2022	BUY	$2.2 - $2.53 $71,500 - $82,225	32,500 New	32,500 $81,000
Q1 2021 May 13, 2021	SELL	$3.48 - $5.3 $715,140 - $1.09 Million	-205,500 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$3.74 - $5.18 $625,290 - $866,044	167,190 Added 436.41%	205,500 $824,000
Q3 2020 Nov 13, 2020	SELL	$4.07 - $7.99 $178,970 - $351,344	-43,973 Reduced 53.44%	38,310 $169,000
Q2 2020 Aug 13, 2020	SELL	$2.69 - $19.21 $137,219 - $979,921	-51,011 Reduced 38.27%	82,283 $545,000
Q1 2020 May 14, 2020	SELL	$2.32 - $6.42 $21,524 - $59,564	-9,278 Reduced 6.51%	133,294 $372,000
Q4 2019 Feb 13, 2020	BUY	$4.95 - $5.96 $210,295 - $253,204	42,484 Added 42.45%	142,572 $814,000
Q3 2019 Nov 13, 2019	BUY	$4.95 - $7.2 $97,034 - $141,141	19,603 Added 24.36%	100,088 $535,000
Q2 2019 Aug 12, 2019	BUY	$5.15 - $15.1 $414,497 - $1.22 Million	80,485 New	80,485 $589,000

Others Institutions Holding ABIO

# of Institutions

Shares Held

7.23M

Call Options Held

54.7K

Put Options Held

View Full List

About ARCA biopharma, Inc.

Ticker ABIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,410,100
Market Cap $48M
Description
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydr...

More about ABIO

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account